ArticleEClinicalMedicine2026

Retraction Notice to "Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study" [eClinicalMedicine 90(2025) 103681].

Cees-Jan Oostwouder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.